GloPID-R COVID-19 Timeline

  • GloPID-R action
  • GloPID-R coordination
  • WHO action
GloPID-R mobilization

GloPID-R mobilization

GloPID-R Members and other major players involved in infectious disease outbreaks worldwide reacted rapidly to this emerging epidemic, working closely with WHO to identify the specific funding research priorities needed to tackle the disease. GloPID-R Chairs and Scientific Advisor immediately launched consultations to coordinate future action in line with the GloPID-R global response strategy.

GloPID-R Members and other major players involved in infectious disease outbreaks worldwide reacted rapidly to this emerging epidemic…

Read more

January 13, 2020

Global Coordination

Global Coordination

GloPID-R attended the Global Coordination Mechanism meeting of the WHO R&D Blueprint

GloPID-R attended the Global Coordination Mechanism meeting of the WHO R&D Blueprint

Read more

March 3, 2020

Coordination

Coordination

GloPID-R Response Strategy Coordination meetings were held to pinpoint research gaps to identify and set research priorities, and select rapid research projects

GloPID-R Response Strategy Coordination meetings were held to pinpoint research gaps to identify and set research priorities, and select rapid research projects

Read more

March 13, 2020

Project Selection

Project Selection

Continuing GloPID-R coordination of rapid funding for research priorities and the selection of relevant projects

GloPID-R continues coordination of rapid funding for research priorities and the selection of relevant projects

Read more

March 27, 2020

Global Coordination

Global Coordination

GloPID-R attended the virtual Global Research and Innovation Forum of the WHO R&D Blueprint

GloPID-R attended the virtual Global Research and Innovation Forum of the WHO R&D Blueprint

Read more

July 1-2, 2020

New variant SARS-CoV-2

New variant SARS-CoV-2

GloPID-R members gathered virtually on December 23, 2020 to discuss the new variant of SARS-CoV-2. GloPID-R Scientific Advisor, Marion Koopmans, presented an understanding of viral mutations and the biological implications; updates were provided by GloPID-R Vice chairs: Jeremy Farrar for the UK and Charles Wiysonge for South Africa. Further information for the UK was given by the University of Oxford and the WHO presented their situation update and expert guidance.

GloPID-R convened members to a web conference to discuss the new variant of SARS-CoV-2.

Read more

December 23, 2020